White Paper – National pharmacare
In February 2018, the federal government announced in its budget the creation of an Advisory Council on the Implementation of National Pharmacare. In a discussion paper published in June 2018, the council identified three key issues:
- Canadians do not have equal access to prescription drugs
- Prescription drug costs are rising sharply
- An increasing number of high-cost drugs are entering the market
In Normandin Beaudry’s White Paper, our experts responded to these issues, based on four guiding principles: access, cost stability, public-private mix and efficiency.
The Advisory Council’s recommendations will be released in spring 2019. In the meantime, Normandin Beaudry will share its position with decision-makers and will continue to assist its clients in getting the most out of this matter. Call us!
Download the white paper